Public annual accounts

WLM PHARMA financials

Name: WLM PHARMA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for WLM PHARMA, with comparable measures and links to available source documents.

Company overview

Registry number

1004458259

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for WLM PHARMA

2025 versus 2024

Operating line: €313,479
EBITDA: €189,426
Total assets: €1,384,702
Equity: €58,427

EBITDA margin +60.4% · Equity ratio +4.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€313,479	€189,426	€1,384,702	€58,427	-
202431 Dec 2024	€310,905	€161,227	€1,532,279	€32,804	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report